274 related articles for article (PubMed ID: 2151197)
1. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
Lijnen P; Fagard R; Staessen J; Amery A
Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
[TBL] [Abstract][Full Text] [Related]
2. Long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Lijnen P; Fagard R; Staessen J; Lissens W; Amery A
J Cardiovasc Pharmacol; 1989 Aug; 14(2):319-25. PubMed ID: 2476608
[TBL] [Abstract][Full Text] [Related]
3. Short-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Lijnen P; Fagard R; Staessen J; Amery A
J Cardiovasc Pharmacol; 1988 Oct; 12(4):461-6. PubMed ID: 2465447
[TBL] [Abstract][Full Text] [Related]
4. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
Joglekar SJ; Jaguste V; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
[TBL] [Abstract][Full Text] [Related]
5. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
Talseth T; Westlie L; Daae L
J Hum Hypertens; 1990 Oct; 4 Suppl 3():39-44. PubMed ID: 2148194
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
Talseth T; Westlie L; Daae LN
J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
[TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
Joglekar SJ; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
[TBL] [Abstract][Full Text] [Related]
8. Nitrendipine and atenolol in essential hypertension in young and middle-aged patients: effect on serum lipids and left ventricular mass.
López NC; Corral JL; Rincón LA; Arreaza MR; Giralt J; Galué GA; Barrios YE; Arocha I
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S101-5. PubMed ID: 1723446
[TBL] [Abstract][Full Text] [Related]
9. Concomitant administration of terazosin and atenolol for the treatment of essential hypertension.
Holtzman JL; Kaihlanen PM; Rider JA; Lewin AJ; Spindler JS; Oberlin JA
Arch Intern Med; 1988 Mar; 148(3):539-43. PubMed ID: 3277569
[TBL] [Abstract][Full Text] [Related]
10. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
Silke B; Guy S; Humphreys JE
J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effect of doxazosin in hypertensive patients: comparison with atenolol.
Baez MA; Garg DC; Jallad NS; Weidler DJ
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):63S-67S. PubMed ID: 2939869
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
Talseth T; Westlie L; Daae L; Vatle S
Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
[TBL] [Abstract][Full Text] [Related]
13. A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.
Frick MH; Halttunen P; Himanen P; Huttunen M; Pörsti P; Pitkäjärvi T; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):55S-62S. PubMed ID: 2939868
[TBL] [Abstract][Full Text] [Related]
14. Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Ott P; Storm TL; Krusell LR; Jensen H; Badskjaer J; Faergeman O
Am J Cardiol; 1987 May; 59(14):73G-77G. PubMed ID: 2884856
[TBL] [Abstract][Full Text] [Related]
15. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
Sourgens H; Schmidt J; Derendorf H
Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
17. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.
Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Beschi M; Castellano M; Muiesan G
J Hum Hypertens; 1992 Feb; 6(1):9-15. PubMed ID: 1349920
[TBL] [Abstract][Full Text] [Related]
18. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
[TBL] [Abstract][Full Text] [Related]
19. Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
Frick MH; Cox DA; Himanen P; Huttunen M; Pitkäjärvi T; Pörsti P; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
Am J Cardiol; 1987 May; 59(14):61G-67G. PubMed ID: 2884854
[TBL] [Abstract][Full Text] [Related]
20. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
Nash DT; Schonfeld G; Reeves RL; Black H; Weidler DJ
Am J Cardiol; 1987 May; 59(14):87G-90G. PubMed ID: 2884859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
